Pictet Asset Management (UK)’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Pictet Asset Management (UK)’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-20,900	Closed	-$347K	–	919
2015 Q3	$347K	Sell	20,900 -65,700	-76%	-$1.32M	﹤0.01%	839
2015 Q2	$1.98M	Sell	86,600 -16,100	-16%	-$397K	0.01%	750
2015 Q1	$2.46M	Buy	102,700 +6,000	+6%	+$152K	0.01%	712
2014 Q4	$2.1M	Hold	96,700	–	–	0.01%	748
2014 Q3	$1.83M	Buy	96,700 +3,000	+3%	+$60.3K	0.01%	745
2014 Q2	$2.18M	Buy	93,700 +12,500	+15%	+$309K	0.01%	726
2014 Q1	$2.73M	Sell	81,200 -900	-1%	-$30.3K	0.01%	682
2013 Q4	$2.42M	Buy	82,100 +15,200	+23%	+$278K	0.01%	702
2013 Q3	$1.02M	Buy	+66,900	New	+$1.24M	0.01%	777

Other funds holding OMED

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pictet Asset Management (UK)'s OMED Position: Q4 2015 in Review

Pictet Asset Management (UK) sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q4 2015, closing a stake of 20,900 shares — an estimated $347K sold.

Pictet Asset Management (UK) first reported a position in OMED in Q3 2013 and held it in 9 quarters. The position peaked at $2.73M in Q1 2014. 83 funds tracked by Wall St. Rank hold OMED as of Q4 2015.

Pictet Asset Management (UK) reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
Pictet Asset Management (UK) sold 20,900 OncoMed Pharmaceuticals, Inc. shares in Q4 2015, an estimated $347K.
Pictet Asset Management (UK) first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 9 quarters.
Pictet Asset Management (UK)'s OncoMed Pharmaceuticals, Inc. position peaked at $2.73M in Q1 2014.
83 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q4 2015.

Based on Pictet Asset Management (UK)'s 13F filing for Q4 2015, filed 12 Feb 2016.